{"timestamp": 1771602496.0589795, "value": {"ticker": "ALLO", "company_name": "Allogene Therapeutics, Inc.", "short_name": "Allogene Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 470809664, "float_shares": 156230149, "shares_outstanding": 224730144, "short_ratio": 3.11, "short_percent_of_float": 0.1008, "shares_short": 18819473, "shares_short_prior": 18077704, "insider_percent_held": 0.1663, "institution_percent_held": 0.65309995, "total_cash": 252194000, "total_debt": 85142000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 27.001, "current_ratio": 8.19, "book_value": 1.413, "price_to_book": 1.482661, "operating_cashflow": -158344992, "free_cashflow": -83917752, "price": 2.095, "52w_high": 3.78, "52w_low": 0.86, "avg_volume": 4296138, "avg_volume_10d": 5372470, "full_time_employees": 226, "audit_risk": 9, "overall_risk": 9}}